dorzolamide and Erythema-Multiforme

dorzolamide has been researched along with Erythema-Multiforme* in 1 studies

Other Studies

1 other study(ies) available for dorzolamide and Erythema-Multiforme

Article	Year
Erythema multiforme after use of topical dorzolamide. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1 Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide. Topics: Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents; Carbonic Anhydrase Inhibitors; Cataract Extraction; Drug Eruptions; Erythema Multiforme; Female; Glaucoma; Humans; Hydrocortisone; Sulfonamides; Thiophenes; Visual Acuity	2008

Article

Year

Erythema multiforme after use of topical dorzolamide.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1

Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide.

Topics: Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents; Carbonic Anhydrase Inhibitors; Cataract Extraction; Drug Eruptions; Erythema Multiforme; Female; Glaucoma; Humans; Hydrocortisone; Sulfonamides; Thiophenes; Visual Acuity

2008